Ant International, Mastercard and Visa Initiate Collaboration on Know-Your-Agent Interoperability to Scale Agentic Commerce
10.9.2026 03:00:00 CEST | Business Wire | Press Release
Ant International, Mastercard, and Visa have begun collaboration on a Know-Your-Agent (KYA) interoperability framework, designed to help card networks, digital wallet ecosystems, agent platforms and marketplaces streamline agent onboarding and identification across networks, based on shared principles while preserving each network's own verification and decisioning processes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260909003891/en/
Ant International, Mastercard and Visa initiate collaboration on Know-Your-Agent interoperability to scale agentic commerce
AI agents are evolving from making recommendations to completing purchases on behalf of users. By 2030, AI agents are projected to orchestrate US$3 trillion to 5 trillion of global consumer commercei. Underlying the mega-trend is the KYA architecture of payment networks and service providers, which establishes requirements and accountability, verifies agent identities, and ensures secure, trusted transaction execution.
The three organizations have previously rolled out their respective protocols — Visa’s Trusted Agent Protocol, Mastercard Verifiable Intent, and Ant International’s Agentic Mobile Protocol — and will now explore opportunities to work towards common principles.
Recognized agent trust signals and streamlined agent onboarding across cards and wallets
The interoperable KYA framework could simplify and facilitate agentic payment transactions for service providers, agent platforms and marketplaces while upholding robust trust guardrails.
With this initiative, agents can benefit from KYA and identity frameworks that enable common trust signals to be recognized across the payment ecosystem. This helps reduce integration complexity and duplicative agent identity verification efforts while maintaining robust trust and risk controls.
This will enable faster time-to-market and lower integration cost for new agentic services with greater trust and risk visibility across participating networks.
The KYA collaboration centers on:
Cross-network Operator Traceability: Each agent is linked to a validated operator, cardholder, or business / organization, enabling clear attribution of agent activity.
Shared Certification Requirements: Each agent is assessed against security and behavioral requirements to ensure it operates as expected.
Continuous Transaction Monitoring: Each agent is continuously monitored and evaluated using a combination of identity and transaction-related signals to support ongoing assessments and certification.
The payments industry is accelerating collaboration to strengthen trust, common principles and governance in the agentic commerce ecosystem, with agent identity and trust as a key area of focus.
Building on the Safeguards for Agentic Finance at Runtime (SAFR) frameworkii, Ant International, Mastercard and Visa will collaborate through BuildFin.ai to advance common approaches for AI agent verification, accountability and risk management across payment ecosystems in Singapore. BuildFin.ai is an industry platform convened by the Monetary Authority of Singapore (MAS) to bring together financial institutions, technology providers and researchers to develop and scale responsible AI solutions for financial services.
The effort aims to support secure and scalable agentic commerce, enabling AI agents to operate safely and reliably across payment ecosystems while maintaining strong safeguards for consumers, merchants and financial institutions.
“As AI agents become a bigger part of how people discover and buy, trust must scale with them," said Rubail Birwadker, Global Head of Growth Products and Strategic Partnerships, Visa. “Visa has played a leading role in creating the trust frameworks that make agentic commerce possible through the development of innovations such as Visa’s Trusted Agent Protocol. Collaborations like this can help create more consistency, better accountability, and greater confidence across the payments ecosystem as AI-driven transactions become more common.”
“Interoperability across Know-Your-Agent frameworks is essential to making agentic commerce work at scale, giving merchants, platforms, wallets and issuers a consistent way to recognise trusted agents, verify that actions reflect the user’s intent, and preserve accountability across the transaction,” said Pablo Fourez, Chief Digital Officer, Mastercard. “Mastercard Verifiable Intent was designed for this open ecosystem, helping ensure that as commerce becomes more autonomous, every interaction remains secure, transparent and grounded in consent.”
“Interoperable KYA between card and wallet networks is critical for securing trust for our payment partners, platforms and merchants in agentic commerce,” said Jiang-Ming Yang, Chief Innovation Officer of Ant International. “We look forward to expanding collaboration as the industry draws on richer signals — capabilities, behavior, execution performance, and risk data — to enhance trust and simplify transactions for our clients and their customers.”
About Ant International
Ant International is a leading global digital payment, digitisation and finAI solutions provider. Through collaboration across the private and public sectors, our unified techfin platform supports financial institutions and merchants of all sizes to achieve inclusive growth through a comprehensive range of cutting-edge digital payment and financial services solutions. To learn more, please visit https://www.ant-intl.com/.
Ant International's Alipay+ is a unified wallet gateway now connecting 150 million merchants to over 50 global digital wallets and banking apps, reaching 2 billion user accounts. The merchant network includes those connected through over 10 national QR schemes across Asia and Middle East.
About Mastercard
Mastercard powers economies and empowers people in 200+ countries and territories worldwide. Together with our customers, we’re building a resilient economy where everyone can prosper. We support a wide range of digital payments choices, making transactions secure, simple, smart and accessible. Our technology and innovation, partnerships and networks combine to deliver a unique set of products and services that help people, businesses and governments realize their greatest potential.
About Visa
Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260909003891/en/
Contacts
Media Contact:
Ant International PR
pr@ant-intl.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom